Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |